The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

AusPAR: Trastucip and Tuzucip

Australian Public Assessment Report

AusPAR

AusPAR: Trastucip and Tuzucip [PDF, 400.61 KB]

AusPAR: Trastucip and Tuzucip [Word, 398.87 KB]

Attachment 01-Product information for Trastucip and Tuzucip [PDF, 516.85 KB]

Attachment 01-Product information for Trastucip and Tuzucip [Word, 245.52 KB]

Attachment 02-Product information for Trastucip and Tuzucip [PDF, 516.97 KB]

Attachment 02-Product information for Trastucip and Tuzucip [Word, 245.78 KB]

Device/Product Name

Trastucip and Tuzucip

Active ingredients

Trastuzumab

AusPAR Date

18 April 2023

Published

26 April 2023

Submission Number

PM-2021-00873-1-4

Submission Type

New biosimilar medicine

Decision

Approved